Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Biotech Growth Trust (The)LSE:BIOG -0.62%39 Shareholder Yield % is 30.58% as of Mar. 2026, which is 293% above its 10-year median of 7.78. GuruFocus rates LSE:BIOG with a GF Score™ of 39/100. The stock has 2 warning signs investors should review. Among 1,486 Asset Management companies, Biotech Growth Trust (The) ranks better than 94.48% on this metric.
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. It is a measure of shareholder return.
As of today, Biotech Growth Trust (The)'s Shareholder Yield % was 30.58%.
Shareholder Yield % is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. The term was coined by William W. Priest of Epoch Investment Partners in a paper in 2005 entitled The Case for Shareholder Yield as a Dominant Driver of Future Equity Returns. William Priest indicated that "shareholder yield is a term that we came up with to reflect the various ways dividends can be paid to owners of a business in a publicly-traded company."
Dividend Yield % shows how much a company pays out in dividends each year relative to its stock price, which is most obvious form of shareholder return.
Buyback Yield % is the net repurchase of shares outstanding over the market capital of the company. Shares repurchases also increase shareholder value by returning the money back to shareholders.
Net Debt Paydown Yield % is the change in average of four quarters of company's total debt over a company's market cap. Assuming the total value of a company remains that same, shareholder value is increased as debt is reduced.
Biotech Growth Trust (The) Shareholder Yield % Related Terms
Biotech Growth Trust (The) Shareholder Yield % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LSE:BIOG vs BLK, BX, KKR: Shareholder Yield % Comparison
For the Asset Management subindustry, Biotech Growth Trust (The)'s Shareholder Yield %, along with its competitors' market caps and Shareholder Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Biotech Growth Trust (The) Shareholder Yield % vs Asset Management Industry
For the Asset Management industry and Financial Services sector, Biotech Growth Trust (The)'s Shareholder Yield % distribution charts can be found below:
* The bar in red indicates where Biotech Growth Trust (The)'s Shareholder Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* All the data are calculated by TTM values. Note that if a companies is traded in several exchanges, then we calculate the company level data for Shareholder Yield % using the primary share class stock data. The calculation result in definition page is for demonstration purpose only, and it's showing the share class level data. Therefore, the numbers in the calculation may differ from elsewhere if the stock is not a primary share.
Biotech Growth Trust (The) (LSE:BIOG) has a Shareholder Yield % of 30.58% as of Mar. 2026. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Biotech Growth Trust (The) and its competitors. This is 293% above median its historical median of 7.78. According to the industry distribution chart, Biotech Growth Trust (The) ranks #82 out of 1486 companies in the Asset Management industry, placing it in the top 5.5%.
Is Biotech Growth Trust (The)'s Shareholder Yield % too high?
Biotech Growth Trust (The)'s current Shareholder Yield % of 30.58% is 293% above median its 10-year median of 7.78. The Asset Management industry median Shareholder Yield % is 4.06. Biotech Growth Trust (The)'s value of 30.58% is 654.1% above this industry median. Based on the distribution chart, Biotech Growth Trust (The) ranks #82 out of 1486 companies in the Asset Management industry, which is in the top quartile — a strong position relative to peers. Overall, Biotech Growth Trust (The) has a GF Score™ of 39/100, reflecting its overall financial health beyond just this single metric.
How does Biotech Growth Trust (The)'s Shareholder Yield % compare to BLK and BX?
According to the Asset Management industry distribution chart, Biotech Growth Trust (The) ranks #82 out of 1486 companies for Shareholder Yield %. This places Biotech Growth Trust (The) in the top 6% of its industry — outperforming the majority of peers. The industry median Shareholder Yield % is 4.06. Biotech Growth Trust (The)'s value of 30.58% is 654.1% above this benchmark. While the company's 10-year median is 7.78 vs. the industry median of 4.06, Biotech Growth Trust (The) has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shareholder Yield % for an Asset Management company?
The median Shareholder Yield % among Asset Management companies is 4.06, based on 1,486 companies in the industry. Companies in the top quartile (top 25%) have a Shareholder Yield % significantly above this median, while those in the bottom quartile fall well below. However, Shareholder Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Biotech Growth Trust (The)'s current Shareholder Yield % of 30.58% is 654.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shareholder Yield % mean?
A high Shareholder Yield % can signal that a stock is expensive relative to its fundamentals. Shareholder Yield is how much money shareholders receive from a company that is in the form of cash dividends, net stock repurchases, and debt reduction. View historical data on Biotech Growth Trust (The) and its competitors. For the Asset Management industry, the median Shareholder Yield % is 4.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Biotech Growth Trust (The)'s current Shareholder Yield % is 30.58%, which is 293% above median its own 10-year median of 7.78. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Biotech Growth Trust (The) stock overvalued right now?
Biotech Growth Trust (The) (LSE:BIOG) has a current Shareholder Yield % of 30.58%. The current Shareholder Yield % is 30.58%, which is 293% above median its 10-year median of 7.78 and 654.1% above the Asset Management industry median of 4.06. Biotech Growth Trust (The)'s overall GF Score™ is 39/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shareholder Yield % calculated?
Shareholder Yield % is calculated from a company's financial statements. For Biotech Growth Trust (The) (LSE:BIOG), the current Shareholder Yield % is 30.58% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Biotech Growth Trust (The) PLC is an externally managed investment trust. Its business objective is to provide its investors with capital appreciation by investing in the biotechnology industry around the world.
39GF Score
Get the complete analysis for LSE:BIOG
Shareholder Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:BIOG has been successfully added to your 
